Syntis Bio
Syntis Bio is a Boston-based biotech (founded 2025 by MIT’s Langer, Traverso & team) developing oral therapies targeting metabolic control in the small intestine.
Currently, there are no issues on this topic.
Find more companies like Syntis Bio
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.